Range
- - -
Vol / Avg.
-/-
Div / Yield
-
52 Wk
0.02 - 0.05
Mkt Cap
14.1M
Payout Ratio
-
Open
-
P/E
-
EPS
0
Shares
181.1M
Outstanding
-
Total Float
-
There is no Press for this Ticker
iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between the cells of the immune system. Geographically, it operates in Canada and Australia.

Related Companies

TickerCompanyChg %Mkt Cap
ICOTFiCo Therapeutics0%14.1M

iCo Therapeutics Company Questions & Answers

Q

How do I buy iCo Therapeutics (ICOTF) stock?

A

You can purchase shares of iCo Therapeutics (OTC: ICOTF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are iCo Therapeutics's (ICOTF) main competitors?

A

There are no as such competitors for iCo Therapeutics.

Q

What is the target price for iCo Therapeutics?

A

There is no analysis for iCo Therapeutics

Q

How much is iCo Therapeutics (ICOTF) stock ?

A

The stock price for iCo Therapeutics (OTC: ICOTF) is $0.078 last updated Mon Mar 22 2021 19:24:37 GMT+0000 (Coordinated Universal Time).

Q

When is the next iCo Therapeutics (ICOTF) dividend?

A

There are no upcoming dividends for iCo Therapeutics.

Q

When is iCo Therapeutics (OTC:ICOTF) reporting earnings?

A

There are no earnings for iCo Therapeutics

Q

When is the upcoming split for ICOTF?

A

There is no upcoming split for iCo Therapeutics.